Bharat Biotech in tie-up with the US-based company FluGen and University of Wisconsin Madison to develop a vaccine named “Coro-Flu” to fight against COVID-19. CoroFlu will build on the backbone of FluGen’s flu vaccine candidate known as M2SR.
Click Here To Get Test Series For SBI PO 2020
The vaccine is being developed on the basis of FluGen’s flu vaccine candidate known as M2SR, a self-limited version of the influenza virus. It induces an immune response against the flu. The vaccine will be built by FluGen’s lab that inserts gene sequences from SARS-CoV-2, the novel coronavirus that causes the disease COVID-19 into M2SR so that the novel vaccine will also induce immunity against the coronavirus.
Important takeaways for all competitive exams:
Adda247, India’s leading platform for government exam preparation, has teamed up with Mangalayatan University, one…
Rafael Nadal, one of tennis's all-time greats, bid farewell to professional tennis at the 2024…
India is all set to host the inaugural Kho Kho World Cup from January 13…
In the July-September 2024 quarter, India's urban unemployment rate decreased to 6.4%, marking the lowest…
The Indian Army successfully conducted the "Sanyukt Vimochan 2024," a Multilateral Annual Joint Humanitarian Assistance…
The state of Uttar Pradesh, known for its rich history and culture, is home to…